Multiple Sclerosis and Related Disorders : Impact Factor & More
eISSN: 2211-0356pISSN: 2211-0348
Share this on:
Key Metrics
CiteScore 
5
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
Scite Index
0.87 5-Year SI
SJR
Q3Neurology
SNIP
1.1
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Multiple Sclerosis and Related Disorders
Multiple Sclerosis and Related Disorders Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ELSEVIER SCI LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Multiple Sclerosis and Related Disorders ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Multiple Sclerosis and Related Disorders
Antinuclear antibody and delayed immunotherapy predict disease evolution in isolated optic neuritis-onset NMOSD: A long-term cohort study.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Failed, Inconclusive or Interrupted Trials in Multiple Sclerosis: 2020-2024 Update.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Prevalence and predictive factors of epilepsy in multiple sclerosis: A cross-sectional study from Saudi Arabia.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Comorbidity of uveitis and multiple sclerosis.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Real-world transition from uncontrolled disease to stability: Three-year Pre-post natalizumab comparison in relapsing multiple sclerosis.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Prescriptions and healthcare use in multiple sclerosis patients within general practices in the Netherlands.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Antinuclear antibody and delayed immunotherapy predict disease evolution in isolated optic neuritis-onset NMOSD: A long-term cohort study.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Failed, Inconclusive or Interrupted Trials in Multiple Sclerosis: 2020-2024 Update.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Prevalence and predictive factors of epilepsy in multiple sclerosis: A cross-sectional study from Saudi Arabia.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Comorbidity of uveitis and multiple sclerosis.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Real-world transition from uncontrolled disease to stability: Three-year Pre-post natalizumab comparison in relapsing multiple sclerosis.
- 1 Jun 2026
- Multiple sclerosis and related disorders
Prescriptions and healthcare use in multiple sclerosis patients within general practices in the Netherlands.
- 1 Jun 2026
- Multiple sclerosis and related disorders
FAQs on Multiple Sclerosis and Related Disorders
How long has Multiple Sclerosis and Related Disorders been actively publishing? 
What is the publishing frequency of Multiple Sclerosis and Related Disorders?
How many articles did Multiple Sclerosis and Related Disorders publish last year?
What is the eISSN & pISSN for Multiple Sclerosis and Related Disorders?
What is Citescore for Multiple Sclerosis and Related Disorders?
What is SNIP score for Multiple Sclerosis and Related Disorders?
What is the SJR for Multiple Sclerosis and Related Disorders?
Who is the publisher of Multiple Sclerosis and Related Disorders?
